Management of Viral Bronchitis
Primary Management: Supportive Care Only
For immunocompetent adults with acute viral bronchitis, no routine pharmacologic treatment is recommended—the cornerstone is supportive care with realistic patient expectations. 1 This includes avoiding antibiotics, antivirals, bronchodilators, corticosteroids, and antitussives in otherwise healthy patients. 1
Key Patient Education Points
- Inform patients that cough typically persists for 10-14 days after the initial visit, which is the normal duration of illness. 1
- Refer to the condition as a "chest cold" rather than "bronchitis" to reduce expectations for antibiotic prescriptions. 1
- Emphasize that antibiotics provide minimal benefit (reducing cough by only half a day) while causing adverse effects including allergic reactions, nausea, vomiting, and Clostridium difficile infection. 2
Symptomatic Relief Options
- For severe cough affecting quality of life, dextromethorphan or codeine may be used for short-term symptomatic relief, reducing cough counts by 40-60%. 1
- Standard analgesics and antipyretics may provide symptomatic relief for associated discomfort and fever. 1
Critical Assessment for Underlying Lung Disease
Up to 45% of patients diagnosed with acute bronchitis actually have underlying asthma or COPD, making this a critical differential diagnosis. 3, 1
When to Suspect Underlying Asthma/COPD
Perform lung function testing in patients with ≥2 of the following features: 3, 1
- Wheezing
- Prolonged expiration
- History of smoking
- Symptoms of allergy
Red Flags Requiring Reassessment
If cough persists or worsens beyond the expected 2-3 week timeframe, reassess with targeted investigations including: 1, 2
- Chest x-ray
- Sputum culture
- Peak flow measurements
- Complete blood count
- Inflammatory markers (CRP)
Management for Patients with Underlying Lung Disease
Patients with underlying COPD or asthma require fundamentally different management approaches. 1
For COPD Exacerbations
- Short-acting β-agonists or anticholinergic bronchodilators should be administered during acute exacerbations. 4
- A short course (10-15 days) of systemic corticosteroids is effective for acute exacerbations. 4
- Antibiotics are indicated for COPD exacerbations, particularly in elderly patients with risk factors (age ≥65 years, FEV1 <50% predicted, ≥4 exacerbations in 12 months, or comorbidities). 5, 4, 6
For Asthma Exacerbations
- β-agonists and steroids have been shown to be beneficial in asthma exacerbations presenting with respiratory symptoms. 3
Common Pitfalls to Avoid
Pitfall #1: Misinterpreting Purulent Sputum
Purulent sputum does NOT indicate bacterial superinfection in acute viral bronchitis and does not justify antibiotics. 1 This is a viral inflammatory response, not bacterial infection.
Pitfall #2: Prescribing Bronchodilators Without Underlying Disease
Wheezing in acute bronchitis does not justify bronchodilators unless underlying asthma/COPD is present. 1 First confirm chronic lung disease before initiating bronchodilator therapy.
Pitfall #3: Inappropriate Antibiotic Use
Viruses are responsible for >90% of acute bronchitis cases. 5, 2 Antibiotics should NOT be prescribed routinely, as they contribute to antibiotic resistance without meaningful clinical benefit. 5
Pitfall #4: Missing Pertussis
Suspect pertussis in patients with cough persisting >2 weeks accompanied by paroxysmal cough, whooping cough, post-tussive emesis, or recent pertussis exposure. 2 This is one of the few scenarios where specific antimicrobial therapy is indicated.
Preventive Measures
- Influenza vaccination is recommended yearly for those at increased risk for complications, including patients aged ≥65 years and those with chronic pulmonary diseases. 3
- Smoking cessation counseling is mandatory, as 90% of patients with chronic bronchitis experience cough resolution after quitting. 5, 4